Exploiting the Diversity of the Heat-Shock Protein Family for Primary and Secondary Tauopathy Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|9|4|623-631

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.9, Iss.4, 2011-12, pp. : 623-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

By Patel Hardik J   Modi Shanu   Chiosis Gabriela   Taldone Tony  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 559-587

Informa Healthcare

Access to resources Recommend Favorite

Post-translational modification of heat-shock protein 90: impact on chaperone function

By Scroggins Bradley T   Neckers Len  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1403-1414

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?

By Isaacs Jennifer S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 569-589

Informa Healthcare

Access to resources Recommend Favorite